These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7105976)

  • 1. The impact of the docent clinical pharmacist on treatment of streptococcal pneumonia.
    Covinsky JO; Hamburger SC; Kelly KL; Pastewski B; Robertson N; Eskridge R; Park G; Twin EJ
    Drug Intell Clin Pharm; 1982; 16(7-8):587-91. PubMed ID: 7105976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A look at the educational responsibilities and cost impact of the docent clinical pharmacist.
    Covinsky JO; Hamburger S; Twin EJ
    Drug Intell Clin Pharm; 1980 Apr; 14(4):266-71. PubMed ID: 10309191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The cost of antibiotics in respiratory disease (author's transl)].
    Léophonte P; Monnier J
    Rev Fr Mal Respir; 1981; 9(6):453-60. PubMed ID: 7330431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pharmacist participation on a medical team on costs, charges, and length of stay.
    Haig GM; Kiser LA
    Am J Hosp Pharm; 1991 Jul; 48(7):1457-62. PubMed ID: 1882873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a multidisciplinary intervention on antibiotic use for nursing home-acquired pneumonia.
    Linnebur SA; Fish DN; Ruscin JM; Radcliff TA; Oman KS; Fink R; Van Dorsten B; Liebrecht D; Fish R; McNulty M; Hutt E
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):442-450.e1. PubMed ID: 22055208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
    Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a clinical pharmacist on antibiotic prescribing. A multicenter trial.
    Thornton JP; Goff DA; Segal R; Guy JT
    J Pharm Technol; 1991; 7(5):195-200. PubMed ID: 10115343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The routine use of urinary pneumococcal antigen test in hospitalised patients with community acquired pneumonia has limited impact for adjustment of antibiotic treatment.
    Piso RJ; Iven-Koller D; Koller MT; Bassetti S
    Swiss Med Wkly; 2012; 142():w13679. PubMed ID: 22965484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pharmacist intervention on antibiotic use and prophylactic antibiotic use in urology clean operations.
    Zhou Y; Ma LY; Zhao X; Tian SH; Sun LY; Cui YM
    J Clin Pharm Ther; 2015 Aug; 40(4):404-8. PubMed ID: 25913640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pneumococcal pneumonia in hospitalized patients. Therapeutic implications of resistances to penicillin and erythromycin].
    Sanz Herrero F; Juan Samper G; Ramón Capilla M; Navarro Iváñez R; Lloret Pérez T
    Med Clin (Barc); 2003 Mar; 120(8):292-4. PubMed ID: 12636898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic prescribing decisions of generalists and infectious disease specialists: thresholds for adopting new drug therapies.
    Metlay JP; Shea JA; Asch DA
    Med Decis Making; 2002; 22(6):498-505. PubMed ID: 12458980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of pneumococcal disease.
    Deegan D
    World Ir Nurs (1995); 1996; 4(1):24-5. PubMed ID: 9456895
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of pharmacists' intervention on the antibiotic therapy for the methicillin-resistant Staphylococcus aureus (MRSA) infectious diseases in the intensive care unit].
    Imaura M; Kohata Y; Kobayashi K; Takahashi H; Yokoyama H; Akase T; Yamada Y
    Yakugaku Zasshi; 2011 Apr; 131(4):563-70. PubMed ID: 21467796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia.
    Naucler P; Darenberg J; Morfeldt E; Ortqvist A; Henriques Normark B
    Thorax; 2013 Jun; 68(6):571-9. PubMed ID: 23442364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal urinary antigen test: diagnostic yield and impact on antibiotic treatment.
    Laijen W; Snijders D; Boersma WG
    Clin Respir J; 2017 Nov; 11(6):999-1005. PubMed ID: 26780500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do clinicians consider the results of the BinaxNOW Streptococcus pneumoniae urinary antigen test when adapting antibiotic regimens for pneumonia patients?
    Matta M; Kernéis S; Day N; Lescat M; Hoi AB; Varon E; Gutmann L; Mainardi JL
    Clin Microbiol Infect; 2010 Sep; 16(9):1389-93. PubMed ID: 19845695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.
    Yayan J
    Drug Des Devel Ther; 2014; 8():1733-43. PubMed ID: 25336917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae.
    Tan TQ; Mason EO; Wald ER; Barson WJ; Schutze GE; Bradley JS; Givner LB; Yogev R; Kim KS; Kaplan SL
    Pediatrics; 2002 Jul; 110(1 Pt 1):1-6. PubMed ID: 12093940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteremia-associated pneumococcal pneumonia and the benefit of initial parenteral antimicrobial therapy.
    Chumpa A; Bachur RG; Harper MB
    Pediatr Infect Dis J; 1999 Dec; 18(12):1081-5. PubMed ID: 10608629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.